Status:
UNKNOWN
Transient Electrocardiogram Assessment in Stroke Evaluation
Lead Sponsor:
Region Gävleborg
Conditions:
Atrial Fibrillation
Stroke
Eligibility:
All Genders
18+ years
Brief Summary
In stroke survivors, atrial fibrillation is typically detected with short-term electrocardiogram (ECG) monitoring in the stroke unit. Prolonged continuous ECG monitoring is impractical and requires su...
Detailed Description
Stroke survivors in Region Gävleborg, Sweden, will be eligible for the study from October 2017. Patients with a history of ischemic stroke without documented atrial fibrillation before or during ECG e...
Eligibility Criteria
Inclusion
- Patients, aged ≥18 years, with a validated diagnosis of ischemic cryptogenic stroke are eligible for the study.
Exclusion
- For screening with chest and thumb-ECG, exclusion criteria are as follows: previously known atrial arrhythmia with an indication for anticoagulation, implantable defibrillator, pacemaker or insertable cardiac monitor, pregnancy, permanent indication for anticoagulation (including low-molecular weight heparin) due to atrial arrhythmia, mechanical heart valve, deep vein thrombosis, or pulmonary embolism. Patients with a life expectancy ≤6 months (e.g. severe heart failure New York Heart Association functional class IV or malignancy) are likewise excluded.
Key Trial Info
Start Date :
October 9 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 9 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03301662
Start Date
October 9 2017
End Date
October 9 2019
Last Update
October 4 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.